<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1579</journal-id><journal-id journal-id-type="pmc-domain">scirep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11078966</article-id><article-id pub-id-type="pmcid-ver">PMC11078966.1</article-id><article-id pub-id-type="pmcaid">11078966</article-id><article-id pub-id-type="pmcaiid">11078966</article-id><article-id pub-id-type="pmid">38719836</article-id><article-id pub-id-type="doi">10.1038/s41598-024-61005-6</article-id><article-id pub-id-type="publisher-id">61005</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Preoperative smoking and robot-assisted radical cystectomy outcomes &amp; complications in multicenter KORARC database</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5978-8179</contrib-id><name name-style="western"><surname>Choi</surname><given-names initials="J">Joongwon</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3246-5246</contrib-id><name name-style="western"><surname>Lee</surname><given-names initials="J">Jooyoung</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0003-3046-7998</contrib-id><name name-style="western"><surname>Hwang</surname><given-names initials="YB">Yu Been</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5399-2184</contrib-id><name name-style="western"><surname>Jeong</surname><given-names initials="BC">Byong Chang</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0844-6843</contrib-id><name name-style="western"><surname>Lee</surname><given-names initials="S">Sangchul</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0391-2342</contrib-id><name name-style="western"><surname>Ku</surname><given-names initials="JH">Ja Hyeon</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3424-2417</contrib-id><name name-style="western"><surname>Nam</surname><given-names initials="JK">Jong Kil</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8566-3353</contrib-id><name name-style="western"><surname>Kim</surname><given-names initials="W">Wansuk</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6775-1157</contrib-id><name name-style="western"><surname>Lee</surname><given-names initials="JY">Ji Youl</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1952-4010</contrib-id><name name-style="western"><surname>Hong</surname><given-names initials="SH">Sung Hoo</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8588-7584</contrib-id><name name-style="western"><surname>Rha</surname><given-names initials="KH">Koon Ho</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2527-4046</contrib-id><name name-style="western"><surname>Han</surname><given-names initials="WK">Woong Kyu</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2246-8838</contrib-id><name name-style="western"><surname>Ham</surname><given-names initials="WS">Won Sik</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1112-7077</contrib-id><name name-style="western"><surname>Kang</surname><given-names initials="SG">Sung Gu</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1524-5233</contrib-id><name name-style="western"><surname>Kang</surname><given-names initials="SH">Seok Ho</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0448-5992</contrib-id><name name-style="western"><surname>Oh</surname><given-names initials="JJ">Jong Jin</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0339-7763</contrib-id><name name-style="western"><surname>Lee</surname><given-names initials="YG">Young Goo</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4390-0952</contrib-id><name name-style="western"><surname>Kwon</surname><given-names initials="TG">Tae Gyun</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4924-4826</contrib-id><name name-style="western"><surname>Kim</surname><given-names initials="TH">Tae-Hwan</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0915-8106</contrib-id><name name-style="western"><surname>Jeon</surname><given-names initials="SH">Seung Hyun</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4509-5846</contrib-id><name name-style="western"><surname>Lee</surname><given-names initials="SH">Sang Hyub</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9777-9238</contrib-id><name name-style="western"><surname>Park</surname><given-names initials="SY">Sung Yul</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8059-6649</contrib-id><name name-style="western"><surname>Yoon</surname><given-names initials="YE">Young Eun</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0611-4554</contrib-id><name name-style="western"><surname>Lee</surname><given-names initials="YS">Yong Seong</given-names></name><address><email>yongslee@cau.ac.kr</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01r024a98</institution-id><institution-id institution-id-type="GRID">grid.254224.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 0789 9563</institution-id><institution>Department of Urology, </institution><institution>Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, </institution></institution-wrap>Gwangmyeong, Korea </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01r024a98</institution-id><institution-id institution-id-type="GRID">grid.254224.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 0789 9563</institution-id><institution>Department of Applied Statistics, </institution><institution>Chung-Ang University, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.264381.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2181 989X</institution-id><institution>Department of Urology, Samsung Medical Center, </institution><institution>Sungkyunkwan University School of Medicine, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cb3km46</institution-id><institution-id institution-id-type="GRID">grid.412480.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 3378</institution-id><institution>Department of Urology, </institution><institution>Seoul National University Bundang Hospital, </institution></institution-wrap>Seongnam, Korea </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04h9pn542</institution-id><institution-id institution-id-type="GRID">grid.31501.36</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5905</institution-id><institution>Department of Urology, </institution><institution>Seoul National University College of Medicine, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04kgg1090</institution-id><institution-id institution-id-type="GRID">grid.412591.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0442 9883</institution-id><institution>Department of Urology, </institution><institution>Pusan National University Yangsan Hospital, </institution></institution-wrap>Yangsan, Korea </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/053fp5c05</institution-id><institution-id institution-id-type="GRID">grid.255649.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 7754</institution-id><institution>Department of Urology, </institution><institution>Ewha Womans University Mokdong Hospital, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/056cn0e37</institution-id><institution-id institution-id-type="GRID">grid.414966.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0647 5752</institution-id><institution>Department of Urology, Seoul St. Mary&#8217;s Hospital, </institution><institution>The Catholic University of Korea College of Medicine, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.15444.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5454</institution-id><institution>Department of Urology, Severance Hospital, </institution><institution>Yonsei University College of Medicine, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.222754.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0840 2678</institution-id><institution>Department of Urology, </institution><institution>Korea University College of Medicine, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03sbhge02</institution-id><institution-id institution-id-type="GRID">grid.256753.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0470 5964</institution-id><institution>Department of Urology, </institution><institution>Hallym University School of Medicine, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/040c17130</institution-id><institution-id institution-id-type="GRID">grid.258803.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0661 1556</institution-id><institution>Department of Urology, </institution><institution>Kyungpook National University School of Medicine, </institution></institution-wrap>Daegu, Korea </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.289247.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 7818</institution-id><institution>Department of Urology, </institution><institution>KyungHee University College of Medicine, </institution></institution-wrap>Seoul, Korea </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/046865y68</institution-id><institution-id institution-id-type="GRID">grid.49606.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 1364 9317</institution-id><institution>Department of Urology, </institution><institution>Hanyang University College of Medicine, </institution></institution-wrap>Seoul, Korea </aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">452196</issue-id><elocation-id>10550</elocation-id><history><date date-type="received"><day>10</day><month>12</month><year>2023</year></date><date date-type="accepted"><day>30</day><month>4</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>08</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>09</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-05-10 00:25:17.400"><day>10</day><month>05</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41598_2024_Article_61005.pdf"/><abstract id="Abs1"><p id="Par1">To investigate the influence of preoperative smoking history on the survival outcomes and complications in a cohort from a large multicenter database. Many patients who undergo radical cystectomy (RC) have a history of smoking; however, the direct association between preoperative smoking history and survival outcomes and complications in patients with muscle-invasive bladder cancer (MIBC) who undergo robot-assisted radical cystectomy (RARC) remains unexplored. We conducted a retrospective analysis using data from 749 patients in the Korean Robot-Assisted Radical Cystectomy Study Group (KORARC) database, with an average follow-up duration of 30.8&#160;months. The cohort was divided into two groups: smokers (n&#8201;=&#8201;351) and non-smokers (n&#8201;=&#8201;398). Propensity score matching was employed to address differences in sample size and baseline demographics between the two groups (n&#8201;=&#8201;274, each). Comparative analyses included assessments of oncological outcomes and complications. After matching, smoking did not significantly affect the overall complication rate (<italic toggle="yes">p</italic>&#8201;=&#8201;0.121). Preoperative smoking did not significantly increase the occurrence of complications based on complication type (p&#8201;=&#8201;0.322), nor did it increase the readmission rate (p&#8201;=&#8201;0.076). There were no perioperative death in either group. Furthermore, preoperative smoking history showed no significant impact on overall survival (OS) [hazard ratio (HR)&#8201;=&#8201;0.87, interquartile range (IQR): 0.54&#8211;1.42; <italic toggle="yes">p</italic>&#8201;=&#8201;0.589] and recurrence-free survival (RFS) (HR&#8201;=&#8201;1.12, IQR: 0.83&#8211;1.53; <italic toggle="yes">p</italic>&#8201;=&#8201;0.458) following RARC for MIBC. The extent of preoperative smoking (&#8804;&#8201;10, 10&#8211;30, and&#8201;&#8805;&#8201;30 pack-years) had no significant influence on OS and RFS in any of the categories (all <italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05). Preoperative smoking history did not significantly affect OS, RFS, or complications in patients with MIBC undergoing RARC.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Bladder cancer</kwd><kwd>Smoking</kwd><kwd>Cystectomy</kwd><kwd>Survival analysis</kwd><kwd>Robot-assisted surgery</kwd></kwd-group><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Urological cancer</kwd><kwd>Bladder cancer</kwd><kwd>Bladder</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>2021R1F1A1048198</award-id><principal-award-recipient><name name-style="western"><surname>Choi</surname><given-names>Joongwon</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Chung-Ang University Research Grants</institution></funding-source><award-id>2023</award-id><principal-award-recipient><name name-style="western"><surname>Choi</surname><given-names>Joongwon</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Bladder cancer poses a significant public health challenge, contributing significantly to global mortality and morbidity. Bladder cancer is the 10th most prevalent cancer globally, with 573,278 new cases and over 200,000 deaths in 2020<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>.</p><p id="Par3">The primary cause of bladder cancer incidence is smoking, with a substantial proportion of patients who undergo radical cystectomy (RC) being current or former smokers<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. The complex composition of tobacco smoke, comprising over 60 carcinogens linked to at least 18 types of cancer, makes smoking the second leading risk factor for mortality<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Cigarette smoking has been established as the most significant risk factor, increasing the risk of bladder cancer by up to fivefold<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>.</p><p id="Par4">Preoperative smoking history correlates with a high tumor stage and grade in patients with newly diagnosed urothelial carcinoma of the bladder, affecting both smoking status and quantity<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. This influence extends to non-muscle invasive bladder cancer (NMIBC), affecting disease recurrence and progression<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>.</p><p id="Par5">Although the correlation between smoking and bladder cancer incidence is well-established, its impact on cancer recurrence following RC in patients with muscle-invasive bladder cancer (MIBC) has been highlighted<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. RC, a complex surgical procedure with a complication rate of 30&#8211;64%<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>, presents post-RC patients who smoke with an increased risk of perioperative complications and the need for re-operative surgery<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. However, the direct association between preoperative smoking history and survival outcomes and complications in patients with MIBC undergoing robot-assisted radical cystectomy (RARC) remains insufficiently explored.</p><p id="Par6">The Korean Robot-Assisted Radical Cystectomy Study Group (KORARC) database, a multicenter repository formed by several institutions, has been instrumental in the development of various bladder cancer-related research outcomes<sup><xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR13">13</xref></sup>. The database comprehensively documents detailed preoperative smoking history, including pack-years.</p><p id="Par7">In this study, we hypothesized that preoperative smoking may impact survival and contribute to wound or infection complications in RARC patients. Consequently, we aimed to investigate the influence of preoperative smoking history on survival outcomes and complications in a cohort derived from a large multicenter database.</p></sec><sec id="Sec2"><title>Patients and methods</title><sec id="Sec3"><title>Data acquisition &amp; analysis</title><p id="Par8">A retrospective analysis was conducted using data from 749 patients enrolled in the Korean Robot-Assisted Radical Cystectomy Study Group (KORARC) database. RARC was performed at 11 tertiary referral centers (21 surgeons) in the Republic of Korea between April 2007 and November 2019. The primary data source was the Korean Society of Endourology and Robotics. The cohort with an average follow-up of 30.8&#160;months, was divided into two groups: 351 smokers and 398 non-smokers. Smokers included both current smokers (those who were actively smoking up to the time of RARC) and ex-smokers with a preoperative smoking history, while non-smokers were defined as individuals who have never smoked.</p><p id="Par9">Propensity score matching was used to address significant differences in sample size and baseline demographics between the two groups. Comparative analyses included demographics, preoperative treatment, intraoperative outcomes, oncological outcomes, and complications (n&#8201;=&#8201;274, each). The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Korea University Anam Hospital (approval number: 2019AN0102). Written informed consent was obtained from all participants.</p></sec><sec id="Sec4"><title>Statistical analysis</title><p id="Par10">Demographic and clinical characteristics were presented as median and interquartile ranges (IQRs) for continuous data and as numbers and percentages for categorical data. Each patient in the preoperative smoking group was matched with a propensity score, using the nearest-neighbor method, to one individual in the preoperative non-smoking group. A logistic regression model was used for the propensity score model, including age, sex, height, weight, body mass index (BMI), American Society of Anesthesiologists (ASA) score, history of preoperative abdominal surgery, history of complications (cardiac, pulmonary, and renal), history of medical conditions (hypertension, diabetes mellitus, hyperlipidemia, and benign prostate hyperplasia), and family history of bladder cancer. Standard mean differences (SMDs) were used to assess the covariate balance between the preoperative smoking and non-smoking groups following propensity score matching. The distribution of confounders was balanced between the two groups when the SMDs were&#8201;&lt;&#8201;10%. Crude incidence rates per 1000 person-years were calculated for overall survival (OS) and recurrence-free survival (RFS). Kaplan&#8211;Meier estimates were used for OS and RFS, stratified by preoperative smoking status.</p><p id="Par11">Using propensity score-matched data, hazard ratios (HRs) and 95% confidence intervals (CIs) for each outcome were estimated using Cox proportional hazard regression models, and robust standard errors were used to determine the correlation between matching pairs. Moreover, logistic regression and multinomial logistic regression models were used to estimate the odds ratios (ORs) and 95% CIs for the incidence, types, and dates of complications using the matched data.</p><p id="Par12">Subgroup analyses were performed according to age (&lt;&#8201;65 and&#8201;&#8805;&#8201;65&#160;years). We assessed the effect of pack-years of smoking as continuous and categorical variables (&#8804;&#8201;10, 10&#8211;30, and&#8201;&#8805;&#8201;30 pack-years of smoking) and on OS and RFS in preoperative smokers using Cox regression models after adjusting for the year of operation, age, sex, height, weight, BMI, ASA, history of preoperative abdominal surgery, history of complications (cardiac, pulmonary, renal), history of medical conditions (hypertension, diabetes mellitus, hyperlipidemia, and benign prostate hyperplasia), and family history of bladder cancer.</p><p id="Par13">We also accessed that achieving pentafecta, composed of negative soft tissue surgical margin, removal of&#8201;&#8805;&#8201;16 lymph nodes, no major complications (Clavien&#8211;Dindo grade 3&#8211;5) within 90&#160;days, no clinical recurrence within the first 12&#160;months, and no ureteroenteric stricture, from previous studies<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, impacts patients' OS and PFS. We investigated whether there was a difference in pentafecta achievement between the smoker and non-smoker groups.</p><p id="Par14">Statistical significance was set at a <italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05 with two-sided tests. All statistical analyses were performed using R version 4.3.1 (The R Foundation for Statistical Computing, Vienna, Austria).</p></sec></sec><sec id="Sec5"><title>Results</title><p id="Par15">The baseline characteristics based on smoking history before and after propensity score matching are presented in Table <xref rid="Tab1" ref-type="table">1</xref>. Before matching, statistically significant differences were found in age, sex, BMI, history of preoperative abdominal surgery, history of benign prostate hyperplasia and diversion type. Before propensity matching, a higher proportion of neobladder was observed in the smoker group (55.3% vs 48.7%, p&#8201;=&#8201;0.029), which may be attributed to the likelihood of a younger patients being included in the smoker group (65 vs 67, p&#8201;=&#8201;0.011). However, after matching, these variables were successfully corrected.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Baseline characteristics by smoking history before and after propensity score matching.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" colspan="3" rowspan="1">Before propensity matching</th><th align="left" colspan="3" rowspan="1">After matching</th></tr><tr><th align="left" colspan="1" rowspan="1">Smoker (n&#8201;=&#8201;351)</th><th align="left" colspan="1" rowspan="1">Non-smoker (n&#8201;=&#8201;398)</th><th align="left" colspan="1" rowspan="1">P value</th><th align="left" colspan="1" rowspan="1">Smoker (n&#8201;=&#8201;274)</th><th align="left" colspan="1" rowspan="1">Non-smoker (n&#8201;=&#8201;274)</th><th align="left" colspan="1" rowspan="1">P value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age, median (IQR)</td><td align="left" colspan="1" rowspan="1">65 (57&#8212;72)</td><td align="left" colspan="1" rowspan="1">67 (59&#8212;74)</td><td char="." align="char" colspan="1" rowspan="1">0.011</td><td align="left" colspan="1" rowspan="1">65 (57&#8212;72)</td><td align="left" colspan="1" rowspan="1">65 (58&#8212;73)</td><td align="left" colspan="1" rowspan="1">0.347</td></tr><tr><td align="left" colspan="1" rowspan="1">Sex, n (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Women</td><td align="left" colspan="1" rowspan="1">3 (0.9)</td><td align="left" colspan="1" rowspan="1">109 (27.4)</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">3 (1.1)</td><td align="left" colspan="1" rowspan="1">3 (1.1)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Men</td><td align="left" colspan="1" rowspan="1">348 (99.1)</td><td align="left" colspan="1" rowspan="1">289 (72.6)</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">271 (98.9)</td><td align="left" colspan="1" rowspan="1">271 (98.9)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Height, median (IQR)</td><td align="left" colspan="1" rowspan="1">167.7 (163&#8212;172)</td><td align="left" colspan="1" rowspan="1">164 (158&#8212;170)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">167.6 (163&#8212;172)</td><td align="left" colspan="1" rowspan="1">167.3 (163&#8211;171)</td><td align="left" colspan="1" rowspan="1">0.427</td></tr><tr><td align="left" colspan="1" rowspan="1">Weight, median (IQR)</td><td align="left" colspan="1" rowspan="1">67.6 (61.2&#8212;74.0)</td><td align="left" colspan="1" rowspan="1">65.0 (56.9&#8212;72.3)</td><td char="." align="char" colspan="1" rowspan="1">&#8201;&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">67.0 (60.5&#8212;73.5)</td><td align="left" colspan="1" rowspan="1">67.5 (60.0&#8211;75.0)</td><td align="left" colspan="1" rowspan="1">0.877</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI, median (IQR)</td><td align="left" colspan="1" rowspan="1">24.2 (22.4&#8212;26.0)</td><td align="left" colspan="1" rowspan="1">24.05 (22.0&#8212;26.4)</td><td char="." align="char" colspan="1" rowspan="1">0.807</td><td align="left" colspan="1" rowspan="1">24 (22.3&#8211;25.9)</td><td align="left" colspan="1" rowspan="1">24.05 (22.1&#8212;26.4)</td><td align="left" colspan="1" rowspan="1">0.544</td></tr><tr><td align="left" colspan="1" rowspan="1">ASA, n (%)</td><td align="left" colspan="1" rowspan="1">2 (1&#8212;2)</td><td align="left" colspan="1" rowspan="1">2 (1&#8212;2)</td><td char="." align="char" colspan="1" rowspan="1">0.415</td><td align="left" colspan="1" rowspan="1">2 (1&#8212;2)</td><td align="left" colspan="1" rowspan="1">2 (1&#8212;2)</td><td align="left" colspan="1" rowspan="1">0.772</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Cardiac</td><td align="left" colspan="1" rowspan="1">33 (9.4)</td><td align="left" colspan="1" rowspan="1">44 (11.1)</td><td char="." align="char" colspan="1" rowspan="1">0.533</td><td align="left" colspan="1" rowspan="1">28 (10.2)</td><td align="left" colspan="1" rowspan="1">27 (9.9)</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Pulmonary</td><td align="left" colspan="1" rowspan="1">27 (7.7)</td><td align="left" colspan="1" rowspan="1">24 (6.0)</td><td char="." align="char" colspan="1" rowspan="1">0.450</td><td align="left" colspan="1" rowspan="1">18 (6.6)</td><td align="left" colspan="1" rowspan="1">16 (5.8)</td><td align="left" colspan="1" rowspan="1">0.859</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Renal</td><td align="left" colspan="1" rowspan="1">55 (15.7)</td><td align="left" colspan="1" rowspan="1">66 (16.6)</td><td char="." align="char" colspan="1" rowspan="1">0.811</td><td align="left" colspan="1" rowspan="1">39 (14.2)</td><td align="left" colspan="1" rowspan="1">44 (16.1)</td><td align="left" colspan="1" rowspan="1">0.634</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;HTN</td><td align="left" colspan="1" rowspan="1">153 (43.6)</td><td align="left" colspan="1" rowspan="1">171 (43.0)</td><td char="." align="char" colspan="1" rowspan="1">0.922</td><td align="left" colspan="1" rowspan="1">115 (42.0)</td><td align="left" colspan="1" rowspan="1">118 (43.1)</td><td align="left" colspan="1" rowspan="1">0.863</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;DM</td><td align="left" colspan="1" rowspan="1">83 (23.6)</td><td align="left" colspan="1" rowspan="1">92 (23.1)</td><td char="." align="char" colspan="1" rowspan="1">0.932</td><td align="left" colspan="1" rowspan="1">58 (21.2)</td><td align="left" colspan="1" rowspan="1">65 (23.7)</td><td align="left" colspan="1" rowspan="1">0.539</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Hyperlipidemia</td><td align="left" colspan="1" rowspan="1">25 (7.1)</td><td align="left" colspan="1" rowspan="1">32 (8.0)</td><td char="." align="char" colspan="1" rowspan="1">0.738</td><td align="left" colspan="1" rowspan="1">19 (6.9)</td><td align="left" colspan="1" rowspan="1">19 (6.9)</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;BPH</td><td align="left" colspan="1" rowspan="1">49 (14.0)</td><td align="left" colspan="1" rowspan="1">27 (6.8)</td><td char="." align="char" colspan="1" rowspan="1">0.002</td><td align="left" colspan="1" rowspan="1">39 (14.2)</td><td align="left" colspan="1" rowspan="1">27 (9.9)</td><td align="left" colspan="1" rowspan="1">0.149</td></tr><tr><td align="left" colspan="1" rowspan="1">Abdominal surgery history, n (%)</td><td align="left" colspan="1" rowspan="1">71 (20.2)</td><td align="left" colspan="1" rowspan="1">109 (27.4)</td><td char="." align="char" colspan="1" rowspan="1">0.028</td><td align="left" colspan="1" rowspan="1">60 (21.9)</td><td align="left" colspan="1" rowspan="1">57 (20.8)</td><td align="left" colspan="1" rowspan="1">0.835</td></tr><tr><td align="left" colspan="1" rowspan="1">Abdominal radiation history, n (%)</td><td align="left" colspan="1" rowspan="1">13 (3.7)</td><td align="left" colspan="1" rowspan="1">11 (2.8)</td><td char="." align="char" colspan="1" rowspan="1">0.602</td><td align="left" colspan="1" rowspan="1">11 (4.0)</td><td align="left" colspan="1" rowspan="1">8 (2.9)</td><td align="left" colspan="1" rowspan="1">0.641</td></tr><tr><td align="left" colspan="1" rowspan="1">Diversion type, n (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td char="." align="char" colspan="1" rowspan="1">0.029</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.108</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Neobladder</td><td align="left" colspan="1" rowspan="1">194 (55.3)</td><td align="left" colspan="1" rowspan="1">194 (48.7)</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">147 (53.6)</td><td align="left" colspan="1" rowspan="1">144 (52.6)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Conduit</td><td align="left" colspan="1" rowspan="1">128 (36.5)</td><td align="left" colspan="1" rowspan="1">148 (37.2)</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">104 (38.0)</td><td align="left" colspan="1" rowspan="1">92 (33.6)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Etc</td><td align="left" colspan="1" rowspan="1">29 (8.3)</td><td align="left" colspan="1" rowspan="1">56 (14.1)</td><td char="." align="char" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">23 (8.4)</td><td align="left" colspan="1" rowspan="1">38 (13.9)</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">BMI</italic> body mass index, <italic toggle="yes">ASA</italic> American Society of Anesthesiologists score, <italic toggle="yes">HTN</italic> hypertension, <italic toggle="yes">DM</italic> diabetes mellitus, <italic toggle="yes">BPH</italic> benign prostate hyperplasia.</p></table-wrap-foot></table-wrap></p><p id="Par16">Postoperative complications were thoroughly assessed to determine whether preoperative smoking history influenced complication rates (Table <xref rid="Tab2" ref-type="table">2</xref>). Preoperative smoking did not significantly increase the occurrence of complications based on complication type (<italic toggle="yes">p</italic>&#8201;=&#8201;0.322), nor did it increase the readmission rate (p&#8201;=&#8201;0.076). Additionally, upon examining the Clavien-Dindo grade, smoking did not increase severe complications of grade 3 or higher (49 vs 59, <italic toggle="yes">p</italic>&#8201;=&#8201;0.173). There were no perioperative death in either group.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Type and Clavien-Dindo grade of complications after matching.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Smoker (n&#8201;=&#8201;274)</th><th align="left" colspan="1" rowspan="1">Non-smoker (n&#8201;=&#8201;274)</th><th align="left" colspan="1" rowspan="1">P value</th></tr></thead><tbody><tr><td align="left" colspan="3" rowspan="1">Complication type, n (%)</td><td char="." align="char" colspan="1" rowspan="1">0.322</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Gastrointestinal</td><td align="left" colspan="1" rowspan="1">37 (25.2)</td><td align="left" colspan="1" rowspan="1">54 (32.7)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Hematological</td><td align="left" colspan="1" rowspan="1">5 (3.4)</td><td align="left" colspan="1" rowspan="1">3 (1.8)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Genitourinary</td><td align="left" colspan="1" rowspan="1">33 (22.4)</td><td align="left" colspan="1" rowspan="1">37 (22.4)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Cardiovascular</td><td align="left" colspan="1" rowspan="1">2 (1.4)</td><td align="left" colspan="1" rowspan="1">2 (1.2)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Pulmonary</td><td align="left" colspan="1" rowspan="1">1 (0.7)</td><td align="left" colspan="1" rowspan="1">5 (3.0)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Infection</td><td align="left" colspan="1" rowspan="1">36 (24.5)</td><td align="left" colspan="1" rowspan="1">36 (21.8)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Wound</td><td align="left" colspan="1" rowspan="1">13 (8.8)</td><td align="left" colspan="1" rowspan="1">5 (3.0)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Neurological</td><td align="left" colspan="1" rowspan="1">2 (1.4)</td><td align="left" colspan="1" rowspan="1">3 (1.8)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Vascular</td><td align="left" colspan="1" rowspan="1">5 (3.4)</td><td align="left" colspan="1" rowspan="1">3 (1.8)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Dermatological</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Etc</td><td align="left" colspan="1" rowspan="1">13 (8.8)</td><td align="left" colspan="1" rowspan="1">17 (10.3)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Readmission rate, n (%)</td><td align="left" colspan="1" rowspan="1">89 (32.5)</td><td align="left" colspan="1" rowspan="1">110 (40.1)</td><td char="." align="char" colspan="1" rowspan="1">0.076</td></tr><tr><td align="left" colspan="3" rowspan="1">Clavien-Dindo grade, n (%)</td><td char="." align="char" colspan="1" rowspan="1">0.173</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;No complication</td><td align="left" colspan="1" rowspan="1">127 (46.4)</td><td align="left" colspan="1" rowspan="1">110 (40.1)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1</td><td align="left" colspan="1" rowspan="1">17 (6.2)</td><td align="left" colspan="1" rowspan="1">11 (4.0)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;2</td><td align="left" colspan="1" rowspan="1">81 (29.6)</td><td align="left" colspan="1" rowspan="1">94 (34.3)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;3A</td><td align="left" colspan="1" rowspan="1">21 (7.7)</td><td align="left" colspan="1" rowspan="1">15 (5.5)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;3B</td><td align="left" colspan="1" rowspan="1">26 (9.5)</td><td align="left" colspan="1" rowspan="1">38 (13.9)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;4A</td><td align="left" colspan="1" rowspan="1">2 (0.7)</td><td align="left" colspan="1" rowspan="1">5 (1.8)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;4B</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">1 (0.4)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;5 (death)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td char="." align="char" colspan="1" rowspan="1"/></tr></tbody></table></table-wrap></p><p id="Par17">In logistic and multinomial logistic regression analysis, we presented whether preoperative smoking increases the risk of complications, particularly infection and wound complications in Table <xref rid="Tab3" ref-type="table">3</xref>. Smoking did not significantly affect overall complication rates (<italic toggle="yes">p</italic>&#8201;=&#8201;0.121). When categorized by type, a preoperative smoking history did not influence infection, wound complications, or other complications (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05).<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Logistic and multinomial logistic regression analyses for the effect of preoperative smoking on complications, the types of complications, and the occurrence of complications by dates.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Outcomes</th><th align="left" colspan="1" rowspan="1">OR</th><th align="left" colspan="1" rowspan="1">95% CI</th><th align="left" colspan="1" rowspan="1">P value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Complications</td><td char="." align="char" colspan="1" rowspan="1">0.77</td><td char="&#x2013;" align="char" colspan="1" rowspan="1">0.54&#8211;1.07</td><td char="." align="char" colspan="1" rowspan="1">0.121</td></tr><tr><td align="left" colspan="4" rowspan="1">Complication types</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Infection and wound</td><td char="." align="char" colspan="1" rowspan="1">1.03</td><td char="&#x2013;" align="char" colspan="1" rowspan="1">0.63&#8211;1.67</td><td char="." align="char" colspan="1" rowspan="1">0.919</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Others</td><td char="." align="char" colspan="1" rowspan="1">0.68</td><td char="&#x2013;" align="char" colspan="1" rowspan="1">0.47&#8211;0.98</td><td char="." align="char" colspan="1" rowspan="1">0.039</td></tr><tr><td align="left" colspan="4" rowspan="1">Complication dates</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Within 30 days</td><td char="." align="char" colspan="1" rowspan="1">0.67</td><td char="&#x2013;" align="char" colspan="1" rowspan="1">0.45&#8211;1.00</td><td char="." align="char" colspan="1" rowspan="1">0.053</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Within 30&#8211;90&#160;days</td><td char="." align="char" colspan="1" rowspan="1">0.88</td><td char="&#x2013;" align="char" colspan="1" rowspan="1">0.58&#8211;1.34</td><td char="." align="char" colspan="1" rowspan="1">0.555</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;After 90&#160;days</td><td char="." align="char" colspan="1" rowspan="1">0.86</td><td char="&#x2013;" align="char" colspan="1" rowspan="1">0.05&#8211;13.92</td><td char="." align="char" colspan="1" rowspan="1">0.916</td></tr></tbody></table></table-wrap></p><p id="Par18">Furthermore, an investigation was conducted to ascertain whether postoperative complications were influenced by smoking status and age (Supplementary Table <xref rid="MOESM1" ref-type="media">3</xref>). Comparing patients who were&#8201;&lt;&#8201;65&#160;years with those who were&#8201;&#8805;&#8201;65&#160;years, we found that, excluding infection and wound complications, the rate of other complications within 30&#160;days was lower in the&#8201;&lt;&#8201;65&#160;years group (OR&#8201;=&#8201;0.49, 0.28&#8211;0.85; <italic toggle="yes">p</italic>&#8201;=&#8201;0.012). Regardless of age, a preoperative smoking history did not have a significant impact on complications within 30&#160;days, 30&#8211;90&#160;days, or beyond 90&#160;days (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05).</p><p id="Par19">We also exploring the impact of the extent of preoperative smoking (&#8804;&#8201;10, 10&#8211;30,&#8201;&#8805;&#8201;30 pack-years) on OS and RFS revealed that smoking had no significant influence on any of the categories (Table <xref rid="Tab4" ref-type="table">4</xref>, <italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05). Whether there is a difference in pentafecta achievement between the two groups is described in Table <xref rid="Tab5" ref-type="table">5</xref>. There was no statistically significant difference in pentafecta achievement based on preoperative smoking status and the five-component of pentafecta (p&#8201;=&#8201;0.122).<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Hazard ratios from Cox models for the effects of pack-years of smoking on overall survival and recurrence-free survival.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">HR (95% CI)</th><th align="left" colspan="1" rowspan="1">P value</th></tr></thead><tbody><tr><td align="left" colspan="3" rowspan="1">Overall survival</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8804;&#8201;10 pack-years of smoking</td><td align="left" colspan="1" rowspan="1">1 (reference)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;10&#8211;30 pack-years of smoking</td><td align="left" colspan="1" rowspan="1">0.93 (0.12, 6.95)</td><td char="." align="char" colspan="1" rowspan="1">0.945</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;30 pack-years of smoking</td><td align="left" colspan="1" rowspan="1">0.57 (0.1, 3.39)</td><td char="." align="char" colspan="1" rowspan="1">0.535</td></tr><tr><td align="left" colspan="3" rowspan="1">Recurrence-free survival</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8804;&#8201;10 pack-years of smoking</td><td align="left" colspan="1" rowspan="1">1 (reference)</td><td char="." align="char" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;10&#8211;30 pack-years of smoking</td><td align="left" colspan="1" rowspan="1">1.61 (0.43, 5.99)</td><td char="." align="char" colspan="1" rowspan="1">0.474</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;30 pack-years of smoking</td><td align="left" colspan="1" rowspan="1">2.23 (0.66, 7.54)</td><td char="." align="char" colspan="1" rowspan="1">0.198</td></tr><tr><td align="left" colspan="1" rowspan="1">Overall survival</td><td align="left" colspan="1" rowspan="1">0.97 (0.94, 1.01)</td><td char="." align="char" colspan="1" rowspan="1">0.108</td></tr><tr><td align="left" colspan="1" rowspan="1">Recurrence-free survival</td><td align="left" colspan="1" rowspan="1">1.01 (0.99, 1.03)</td><td char="." align="char" colspan="1" rowspan="1">0.199</td></tr></tbody></table><table-wrap-foot><p>Adjusted for OP year, age, sex, height, weight, BMI, ASA, PRE abdominal surgery history, complication (cardiac, pulmonary, renal, HTN, DM, Hyperlipidemia, BPH), family history.</p></table-wrap-foot></table-wrap><table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Pentafecta achievement after matching.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Smoker (n&#8201;=&#8201;274)</th><th align="left" colspan="1" rowspan="1">Non-smoker (n&#8201;=&#8201;274)</th><th align="left" colspan="1" rowspan="1">P value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Pentafecta achievement (%)</td><td align="left" colspan="1" rowspan="1">99 (36.1)</td><td align="left" colspan="1" rowspan="1">81 (29.6)</td><td char="." align="char" colspan="1" rowspan="1">0.122</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Negative soft tissue surgical margin</td><td align="left" colspan="1" rowspan="1">261 (95.3)</td><td align="left" colspan="1" rowspan="1">265 (96.7)</td><td char="." align="char" colspan="1" rowspan="1">0.514</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#8201;16 lymph nodes removed</td><td align="left" colspan="1" rowspan="1">154 (56.2)</td><td align="left" colspan="1" rowspan="1">142 (51.8)</td><td char="." align="char" colspan="1" rowspan="1">0.346</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;No major complications (Clavien&#8211;Dindo grade 3&#8211;5) within 90&#160;days</td><td align="left" colspan="1" rowspan="1">225 (82.1)</td><td align="left" colspan="1" rowspan="1">215 (78.5)</td><td char="." align="char" colspan="1" rowspan="1">0.334</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;No clinical recurrence within the first 12&#160;months</td><td align="left" colspan="1" rowspan="1">221 (80.7)</td><td align="left" colspan="1" rowspan="1">230 (83.9)</td><td char="." align="char" colspan="1" rowspan="1">0.371</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;No ureteroenteric stricture</td><td align="left" colspan="1" rowspan="1">252 (92.0)</td><td align="left" colspan="1" rowspan="1">246 (89.8)</td><td char="." align="char" colspan="1" rowspan="1">0.458</td></tr></tbody></table></table-wrap></p><p id="Par20">The incidence rates per 1000 person-years and HRs from the Cox models for each outcome comparing the smoker and non-smoker groups are shown in Supplementary Table <xref rid="MOESM1" ref-type="media">1</xref>. After matching, preoperative smoking history did not significantly impact OS (HR&#8201;=&#8201;0.87, IQR: 0.54&#8211;1.42; <italic toggle="yes">p</italic>&#8201;=&#8201;0.589) and RFS (HR&#8201;=&#8201;1.12, IQR: 0.83&#8211;1.53; <italic toggle="yes">p</italic>&#8201;=&#8201;0.458) after RARC for MIBC. A detailed Kaplan&#8211;Meier curve is shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Kaplan&#8211;Meier curves. Kaplan&#8211;Meier curves for overall and recurrence-free survival according to smoking status.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="41598_2024_61005_Fig1_HTML.jpg"/></fig></p><p id="Par21">To investigate whether age influences survival due to preoperative smoking history, a survival comparison was conducted by categorizing patients into groups based on age, namely&#8201;&lt;&#8201;65&#160;years and&#8201;&#8805;&#8201;65&#160;years (Supplementary Table <xref rid="MOESM1" ref-type="media">2</xref>). Regardless of age group, preoperative smoking history did not affect OS or RFS (all <italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05).</p></sec><sec id="Sec6"><title>Discussion</title><p id="Par22">In our study, preoperative smoking history before RARC did not affect patient survival or postoperative complications. This contradicts previous findings that smoking influences RC outcomes. However, further research is warranted to interpret these results due to the large-volume multicenter database and propensity score matching employed in our investigation.</p><p id="Par23">We conducted various subgroup analyses, comparing survival, smoking frequency, age, and early and late postoperative complications. However, no significant differences were observed between the two groups. Given the higher likelihood of postoperative complications in patients who undergo radical cystectomy than in those who undergo other surgeries, multidisciplinary discussions are essential, and postoperative care must be comprehensive to effectively manage risk factors such as smoking status<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>.</p><p id="Par24">Approximately half of bladder cancer cases are attributed to tobacco smoking<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. For patients undergoing RARC, physicians should strongly recommend smoking cessation. While unable to reflect postoperative smoking status, our study affirms that preoperative smoking history does not affect OS and RFS in patients with RARC. These results suggest that smoking cessation after surgery may potentially have a more significant impact on survival.</p><p id="Par25">RARC is associated with reduced incisions and lower blood loss compared with open RC, possibly resulting in fewer postoperative complications. Additionally, the feasibility of RARC has been reported in T4 cases and is not limited to T3 or below<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Therefore, preoperative factors, such as smoking, may be less likely to have an impact on RARC different from that on open RC. Previous studies have reported an increased Clavien III-V complication rate in current smokers following RC (13.1% vs. 7.4%)<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Our study, focusing on patients undergoing RARC, specifically investigated the influence of preoperative smoking history and found distinctions. Furthermore, the lower incidence of complications seen in our study may be attributable to age, as the average age in our study was 65&#160;years, whereas it was 69&#160;years in the previous study. Particularly, smoking status has been reported to influence complications in older patients aged&#8201;&#8805;&#8201;70&#160;years<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. However, in our study, focusing on RARC patients&#8201;&#8805;&#8201;65&#160;years, no statistically significant differences were found.</p><p id="Par26">In the STOP-OP randomized controlled trial, a preoperative 6-week intensive smoking and/or alcohol cessation intervention was conducted to assess its impact on postoperative complications following RC. However, the intervention did not influence postoperative complications following radical cystectomy<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. A previous meta-analysis suggested that smoking status is associated with an increased risk of major postoperative complications, infections, and mortality after RC; however, most of the data were from patients who underwent open RC<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. A previous study reported a controversial relationship between smoking and RC, where current smoking status had a selection effect, and no adverse bladder cancer-related outcomes were present among current smokers after RC<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>.</p><p id="Par27">Pelvic radiotherapy can also have a significant impact on post-radical cystectomy complications. In our study, although there was no difference in the rate of radiation therapy between the two groups (4.0% vs 2.9%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.641), a study involving 682 patients investigating the influence of radiation therapy reported that 75.1% of patients with pelvic radiotherapy experienced complications after radical cystectomy. Furthermore, urinary tract infection (19%) was reported to be the most common complication, emphasizing the need for careful post-operative management in such patients<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>.</p><p id="Par28">Venous thromboembolism (VTE) is another rare but significant complication associated with radical cystectomy that can increase perioperative mortality. Upon examining our data, we found three cases of VTE events, with two cases classified as Clavien grade 2 and one case as grade 3. In a large-scale study on VTE following radical cystectomy, a VTE incidence rate of 4% was reported, with 24% resulting in fatalities, and the median time to VTE occurrence was reported to be 11&#160;days post-surgery<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>.</p><p id="Par29">Our study had several limitations. First, the study was retrospective in nature. Smoking status was only assessed preoperatively; information regarding postoperative smoking cessation was not investigated. Therefore, the results of this study should be interpreted from the perspective of preoperative smoking status. Second, the database lacked details regarding he time at which ex-smokers ceased smoking; it only provided the total quantity smoked. Consequently, differentiating between individuals who had quit smoking 10&#160;years prior and those who had quit a month ago was not feasible. Third, due to the limited number of current smokers in this study, we were unable to analyze current smokers and ex-smokers separately. Fourth, we investigated only the presence of medical diseases as categorical data and did not collect data on laboratory parameters such as renal and hepatic function. Concurrent comorbidities associated with this may also potentially influence complication rates.</p><p id="Par30">Nonetheless, the significance of these data lies in assessing the impact of preoperative smoking history within a more uniform patient population, focusing solely on the outcomes of patients undergoing RARC.</p></sec><sec id="Sec7"><title>Conclusion</title><p id="Par31">In conclusion, the preoperative smoking history of patients with MIBC did not exhibit any significant impacts on OS, RFS, or complications in patients who underwent RARC.</p></sec><sec sec-type="supplementary-material"><sec id="Sec8"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41598_2024_61005_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Tables.</p></caption></media></supplementary-material></p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1038/s41598-024-61005-6.</p></sec><notes notes-type="author-contribution"><title>Author contributions</title><p>Research conception and design: YS Lee. Data analysis and interpretation: J Lee, YB Hwang. Drafting of the manuscript: J Choi. Obtaining database: BC Jeong, S Lee, JH Ku, JK Nam, W Kim, JY Lee, SH Hong, KH Rha, WK Han, WS Ham, SG Kang, SH Kang, JJ Oh, YG Lee, TG Kwon, T-H Kim, SH Jeon, SH Lee, SY Park, YE Yoon, Obtaining funding: J Choi. Administrative, technical, or material support: YS Lee, Approval of the final manuscript: BC Jeong, YS Lee.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIT) (No. 2021R1F1A1048198) and the Chung-Ang University Research Grants in 2023.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets generated and/or analyzed in the current study are available from the corresponding author upon reasonable request.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par32">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tfaily</surname><given-names>MA</given-names></name><name name-style="western"><surname>Tamim</surname><given-names>H</given-names></name><name name-style="western"><surname>El Hajj</surname><given-names>A</given-names></name><name name-style="western"><surname>Mukherji</surname><given-names>D</given-names></name></person-group><article-title>Muscle invasive bladder cancer and radical cystectomy: A risk predictive model</article-title><source>Ecancermedicalscience.</source><year>2022</year><volume>16</volume><fpage>1456</fpage><pub-id pub-id-type="doi">10.3332/ecancer.2022.1456</pub-id><pub-id pub-id-type="pmid">36405942</pub-id><pub-id pub-id-type="pmcid">PMC9666275</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beech</surname><given-names>BB</given-names></name><name name-style="western"><surname>Doudt</surname><given-names>AD</given-names></name><name name-style="western"><surname>Sjoberg</surname><given-names>DD</given-names></name><etal/></person-group><article-title>Association of smoking history on health-related quality of life in patients undergoing radical cystecomy</article-title><source>Urol. Oncol.</source><year>2023</year><volume>41</volume><issue>325</issue><fpage>e9</fpage><lpage>e14</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.urolonc.2022.12.009</pub-id><pub-id pub-id-type="pmcid">PMC10272017</pub-id><pub-id pub-id-type="pmid">36631370</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rink</surname><given-names>M</given-names></name><name name-style="western"><surname>Zabor</surname><given-names>EC</given-names></name><name name-style="western"><surname>Furberg</surname><given-names>H</given-names></name><etal/></person-group><article-title>Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy</article-title><source>Eur. Urol.</source><year>2013</year><volume>64</volume><fpage>456</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2012.11.039</pub-id><pub-id pub-id-type="pmid">23206854</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freedman</surname><given-names>ND</given-names></name><name name-style="western"><surname>Silverman</surname><given-names>DT</given-names></name><name name-style="western"><surname>Hollenbeck</surname><given-names>AR</given-names></name><name name-style="western"><surname>Schatzkin</surname><given-names>A</given-names></name><name name-style="western"><surname>Abnet</surname><given-names>CC</given-names></name></person-group><article-title>Association between smoking and risk of bladder cancer among men and women</article-title><source>JAMA</source><year>2011</year><volume>17</volume><issue>306</issue><fpage>737</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1001/jama.2011.1142</pub-id><pub-id pub-id-type="pmcid">PMC3441175</pub-id><pub-id pub-id-type="pmid">21846855</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>CH</given-names></name><name name-style="western"><surname>Shun</surname><given-names>CT</given-names></name><name name-style="western"><surname>Huang</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer</article-title><source>BJU Int.</source><year>2007</year><volume>100</volume><fpage>281</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1111/j.1464-410X.2007.06873.x</pub-id><pub-id pub-id-type="pmid">17419696</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogihara</surname><given-names>K</given-names></name><name name-style="western"><surname>Kikuchi</surname><given-names>E</given-names></name><name name-style="western"><surname>Yuge</surname><given-names>K</given-names></name><etal/></person-group><article-title>Refraining from smoking for 15 years or more reduced the risk of tumor recurrence in non-muscle invasive bladder cancer patients</article-title><source>Ann. Surg. Oncol.</source><year>2016</year><volume>23</volume><fpage>1752</fpage><lpage>1759</lpage><pub-id pub-id-type="doi">10.1245/s10434-015-5016-z</pub-id><pub-id pub-id-type="pmid">26671037</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lauridsen</surname><given-names>SV</given-names></name><name name-style="western"><surname>Thomsen</surname><given-names>T</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Effect of a smoking and alcohol cessation intervention initiated shortly before radical cystectomy&#8212;The STOP-OP Study: A randomised clinical trial</article-title><source>Eur. Urol. Focus</source><year>2022</year><volume>8</volume><fpage>1650</fpage><lpage>1658</lpage><pub-id pub-id-type="doi">10.1016/j.euf.2022.02.005</pub-id><pub-id pub-id-type="pmid">35241394</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reese</surname><given-names>SW</given-names></name><name name-style="western"><surname>Ji</surname><given-names>E</given-names></name><name name-style="western"><surname>Paciotti</surname><given-names>M</given-names></name><etal/></person-group><article-title>Risk factors and reasons for reoperation after radical cystectomy</article-title><source>Urol. Oncol.</source><year>2020</year><volume>38</volume><fpage>269</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.urolonc.2019.10.011</pub-id><pub-id pub-id-type="pmid">31761610</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sathianathen</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Weight</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Jarosek</surname><given-names>SL</given-names></name><name name-style="western"><surname>Konety</surname><given-names>BR</given-names></name></person-group><article-title>Increased surgical complications in smokers undergoing radical cystectomy</article-title><source>Bladder Cancer.</source><year>2018</year><volume>29</volume><issue>4</issue><fpage>403</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.3233/BLC-180185</pub-id><pub-id pub-id-type="pmcid">PMC6218107</pub-id><pub-id pub-id-type="pmid">30417051</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><name name-style="western"><surname>Ku</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Oncological outcome according to attainment of pentafecta after robot-assisted radical cystectomy in patients with bladder cancer included in the multicentre KORARC database</article-title><source>BJU Int.</source><year>2021</year><volume>127</volume><fpage>182</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1111/bju.15178</pub-id><pub-id pub-id-type="pmid">32682331</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shim</surname><given-names>JS</given-names></name><name name-style="western"><surname>Noh</surname><given-names>TI</given-names></name><name name-style="western"><surname>Ku</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Effect of intraoperative fluid volume on postoperative ileus after robot-assisted radical cystectomy</article-title><source>Sci. Rep.</source><year>2021</year><volume>18</volume><issue>11</issue><fpage>10522</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-89806-z</pub-id><pub-id pub-id-type="pmcid">PMC8131600</pub-id><pub-id pub-id-type="pmid">34006918</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Shim</surname><given-names>JS</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>TG</given-names></name><etal/></person-group><article-title>Gender-related outcomes in robot-assisted radical cystectomy: A multi-institutional study</article-title><source>Investig. Clin. Urol.</source><year>2022</year><volume>63</volume><fpage>53</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.4111/icu.20210334</pub-id><pub-id pub-id-type="pmid">34983123</pub-id><pub-id pub-id-type="pmcid">PMC8756158</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>BC</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><etal/></person-group><article-title>Predicting factor analysis of postoperative complications after robot-assisted radical cystectomy: Multicenter KORARC database study</article-title><source>Int. J. Urol.</source><year>2022</year><volume>29</volume><fpage>939</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1111/iju.14815</pub-id><pub-id pub-id-type="pmid">35137466</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knorr</surname><given-names>JM</given-names></name><name name-style="western"><surname>Ericson</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Comparison of major complications at 30 and 90 days following radical cystectomy</article-title><source>Urology.</source><year>2021</year><volume>148</volume><fpage>192</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.urology.2020.08.038</pub-id><pub-id pub-id-type="pmid">32888983</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boeri</surname><given-names>L</given-names></name><name name-style="western"><surname>Soligo</surname><given-names>M</given-names></name><name name-style="western"><surname>Frank</surname><given-names>I</given-names></name><etal/></person-group><article-title>Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: A single-centre experience</article-title><source>BJU Int.</source><year>2019</year><volume>123</volume><fpage>1011</fpage><lpage>1019</lpage><pub-id pub-id-type="doi">10.1111/bju.14612</pub-id><pub-id pub-id-type="pmid">30623554</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mori</surname><given-names>K</given-names></name><name name-style="western"><surname>Mostafaei</surname><given-names>H</given-names></name><name name-style="western"><surname>Abufaraj</surname><given-names>M</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Egawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Shariat</surname><given-names>SF</given-names></name></person-group><article-title>Smoking and bladder cancer: Review of the recent literature</article-title><source>Curr. Opin. Urol.</source><year>2020</year><volume>30</volume><fpage>720</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1097/MOU.0000000000000804</pub-id><pub-id pub-id-type="pmid">32701723</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Daghmin</surname><given-names>A</given-names></name><name name-style="western"><surname>Kauffman</surname><given-names>EC</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: Results from the International Radical Cystectomy Consortium (IRCC)</article-title><source>BJU Int.</source><year>2014</year><volume>114</volume><fpage>98</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1111/bju.12569</pub-id><pub-id pub-id-type="pmid">24219170</pub-id><pub-id pub-id-type="pmcid">PMC4196689</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haeuser</surname><given-names>L</given-names></name><name name-style="western"><surname>Marchese</surname><given-names>M</given-names></name><name name-style="western"><surname>Schrag</surname><given-names>D</given-names></name><etal/></person-group><article-title>The impact of smoking on radical cystectomy complications increases in elderly patients</article-title><source>Cancer.</source><year>2021</year><volume>1</volume><issue>127</issue><fpage>1387</fpage><lpage>1394</lpage><pub-id pub-id-type="doi">10.1002/cncr.33308</pub-id><pub-id pub-id-type="pmid">33351967</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tellini</surname><given-names>R</given-names></name><name name-style="western"><surname>Mari</surname><given-names>A</given-names></name><name name-style="western"><surname>Muto</surname><given-names>G</given-names></name><etal/></person-group><article-title>Impact of smoking habit on perioperative morbidity in patients treated with radical cystectomy for urothelial bladder cancer: A systematic review and meta-analysis</article-title><source>Eur. Urol. Oncol.</source><year>2021</year><volume>4</volume><fpage>580</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1016/j.euo.2020.10.006</pub-id><pub-id pub-id-type="pmid">33160975</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Froehner</surname><given-names>M</given-names></name><name name-style="western"><surname>Koch</surname><given-names>R</given-names></name><name name-style="western"><surname>Hubler</surname><given-names>M</given-names></name><etal/></person-group><article-title>Selection effects may explain smoking-related outcome differences after radical cystectomy</article-title><source>Eur. Urol. Focus</source><year>2018</year><volume>4</volume><fpage>395</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1016/j.euf.2016.10.003</pub-id><pub-id pub-id-type="pmid">28753798</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gontero</surname><given-names>P</given-names></name><name name-style="western"><surname>Pisano</surname><given-names>F</given-names></name><name name-style="western"><surname>Palou</surname><given-names>J</given-names></name><etal/></person-group><article-title>Complication rate after cystectomy following pelvic radiotherapy: An international, multicenter, retrospective series of 682 cases</article-title><source>World J. Urol.</source><year>2020</year><volume>38</volume><fpage>1959</fpage><lpage>1968</lpage><pub-id pub-id-type="doi">10.1007/s00345-019-02982-6</pub-id><pub-id pub-id-type="pmid">31691084</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laymon</surname><given-names>M</given-names></name><name name-style="western"><surname>Harraz</surname><given-names>A</given-names></name><name name-style="western"><surname>Elshal</surname><given-names>A</given-names></name><etal/></person-group><article-title>Venous thromboembolism after radical cystectomy and urinary diversion: A single-center experience with 1737 consecutive patients</article-title><source>Scand. J. Urol.</source><year>2019</year><volume>53</volume><fpage>392</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1080/21681805.2019.1698652</pub-id><pub-id pub-id-type="pmid">31830847</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>